Bristol-Myers Squibb Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
15 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ZEPOSIA ozanimod 920 microgram capsules blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OPDIVO nivolumab 240 mg in 24 mL (10 mg/mL) concentrate solution for IV infusion vial.
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd
-
Designation or determinationPriority review
-
Designation or determinationPriority review
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.